Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece.
about
Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational studyNew data concerning the epidemiology of Hepatitis B virus infection in GreecePrevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus.Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, ChinaInfection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009.Occult hepatitis B virus infection and blood transfusionOccult hepatitis B virus infection: implications in transfusion.Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees.Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.Occult hepatitis B virus infection among Egyptian blood donors.Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcomePrevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran.Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi ArabiaMolecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia.Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission.Clinical and epidemiological profile of female blood donors with positive serology for viral hepatitis B.An overview of occult hepatitis B virus infection.Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western Greece.Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.Prevalence of viral markers among first-time Arab blood donors in Kuwait.
P2860
Q24798262-8576072F-241B-4446-AC33-E79A893E1DCCQ33369855-7958983E-0D6F-465D-913B-C64BE96F028AQ33590821-E3BD1042-D613-469C-962C-C02DD7D28FA4Q33866297-CC694F79-D930-429D-AC65-8FD800DC1E08Q34097882-2F0BF490-1616-4CA1-92C8-2D21839F5123Q34677180-177BF679-5617-4322-95FF-9B97F30FEE49Q34692987-60F5DDC8-E82B-49AD-BB67-E4050767C707Q35237335-137E68EB-EC01-45F4-8FC0-12B42E25303DQ35691937-B0AE4AE0-F0F9-45EC-A67F-791BC9094C51Q35762179-AB59B016-6351-4B80-ABA2-66658669E235Q36654281-0F3FC6E1-7CE4-4BA3-9445-7E8FD3F8808CQ36812851-6AAB11BC-D067-4143-972B-B13CCB005558Q37266330-062A4F09-5F85-40B3-903D-0039D9A29430Q37304270-0E45D39A-4B3D-434A-8362-3AD60D2EE47BQ37359249-A0CD78E4-772D-4678-A7DF-A8F0C8D7E1C0Q37418340-748EDEA0-C977-4431-8086-B74B654A2E53Q37958234-89D72F96-8776-460B-BEE5-7B2F13D16A99Q38990467-C50C83CF-8AB7-4BAF-93EA-06BA615B6640Q40375670-C369B138-B3B8-4000-AEC8-171ADA38E6D4Q42722415-9CA6C72A-A102-41D8-973C-174F5A9147F2Q42977683-C76AB8D7-0BB4-45BE-B3AD-4429E0D20BF3Q42981169-1B13BE42-D3D8-4F15-8F18-AEB18E904A97Q43714409-02DAF3B1-E0D1-4742-9F14-73645D0361ABQ45195135-2EE50CE8-4767-4C5A-B223-D2E8F3A83DE9Q45619475-4EDC96DE-9F14-4662-AE25-8236C64A49EEQ54302986-71694142-0EF6-4489-94F3-76E7C255BCF5
P2860
Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Value of anti-HBc screening of ...... study in Northwestern Greece.
@en
Value of anti-HBc screening of ...... study in Northwestern Greece.
@nl
type
label
Value of anti-HBc screening of ...... study in Northwestern Greece.
@en
Value of anti-HBc screening of ...... study in Northwestern Greece.
@nl
prefLabel
Value of anti-HBc screening of ...... study in Northwestern Greece.
@en
Value of anti-HBc screening of ...... study in Northwestern Greece.
@nl
P2093
P2860
P1433
P1476
Value of anti-HBc screening of ...... study in Northwestern Greece.
@en
P2093
P2860
P304
P356
10.1046/J.1537-2995.2001.41050652.X
P577
2001-05-01T00:00:00Z